Placebo-controlled trial of a combination of bemetizide and triamterene ('Hypertane') in mild or moderate hypertension. 1983

R Hornung, and H Keiso, and E B Raftery, and J R Whittington

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females

Related Publications

R Hornung, and H Keiso, and E B Raftery, and J R Whittington
January 1983, Current medical research and opinion,
R Hornung, and H Keiso, and E B Raftery, and J R Whittington
October 1978, Die Medizinische Welt,
R Hornung, and H Keiso, and E B Raftery, and J R Whittington
January 1982, Biopharmaceutics & drug disposition,
R Hornung, and H Keiso, and E B Raftery, and J R Whittington
October 1982, Deutsche medizinische Wochenschrift (1946),
R Hornung, and H Keiso, and E B Raftery, and J R Whittington
January 1982, Wiener klinische Wochenschrift,
R Hornung, and H Keiso, and E B Raftery, and J R Whittington
December 1978, Die Medizinische Welt,
R Hornung, and H Keiso, and E B Raftery, and J R Whittington
January 1979, British journal of clinical pharmacology,
R Hornung, and H Keiso, and E B Raftery, and J R Whittington
January 1986, Postgraduate medical journal,
R Hornung, and H Keiso, and E B Raftery, and J R Whittington
December 1992, British journal of obstetrics and gynaecology,
R Hornung, and H Keiso, and E B Raftery, and J R Whittington
November 1984, The American journal of medicine,
Copied contents to your clipboard!